# FDA Inspection 1262215 - WuXi Advanced Therapies - February 07, 2025

Source: https://www.keypedia.com/records/fda_inspections/wuxi-advanced-therapies/b2abda4e-18e9-4bae-bfb9-d3361e7d2540
Source feed: FDA_Inspections

> FDA Inspection 1262215 for WuXi Advanced Therapies on February 07, 2025. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1262215
- Company Name: WuXi Advanced Therapies
- Inspection Date: 2025-02-07
- Product Type: Human Drugs
- Office Name: Philadelphia District Office

## Related Documents

- [FDA Inspection 1299454 - 2025-11-25](https://www.keypedia.com/records/fda_inspections/wuxi-advanced-therapies/3ea12386-b657-449c-b644-e365d8fe3cee)
- [FDA Inspection 1299454 - 2025-11-25](https://www.keypedia.com/records/fda_inspections/wuxi-advanced-therapies/1f18cb39-7ccf-4206-9dc5-548c27bdc8b5)
- [FDA Inspection 1262215 - 2025-02-07](https://www.keypedia.com/records/fda_inspections/wuxi-advanced-therapies/b947c96b-65c6-4ce5-b651-258f5e4a8432)
- [FDA Inspection 1121335 - 2020-01-22](https://www.keypedia.com/records/fda_inspections/wuxi-advanced-therapies/0a449cf5-20ff-4805-b457-1937e3622faa)
- [FDA Inspection 921995 - 2015-04-17](https://www.keypedia.com/records/fda_inspections/wuxi-advanced-therapies/c0b6184b-9c4a-43f0-b96a-8c40e321304f)

Company: https://www.keypedia.com/companies/wuxi-advanced-therapies/2d12016c-2b9d-4b5e-91a8-4f8af5bee2e1

Office: https://www.keypedia.com/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8